Dr Richard Kaszynski on antivirals
Updated: May 20, 2022
Season 1: 16 Nov 2021
This week, GOLD talks to Dr Richard Kaszynski, Chief Medical Officer, AiPharma, who discusses the emerging role of antivirals in healthcare. He explores his work on the GUARDIAN programme, the benefits of drug repurposing, the importance of keeping patients out of hospitals and his highlights from the past year.
A little more on GOLD’s guest…
Dr Richard Kaszynski is the Chief Medical Officer at AiPharma, and the co-founder of GUARDIAN, developed in collaboration with Imperial College London. He was previously the Senior Medical Advisor to the Democratic Republic of Congo, where he worked with the coordinator general of the Ebola response to combat and contain the Ebola outbreak. He also acted as the lead clinician on the anti-infectious disease team at the Tokyo Olympics earlier this year.
Topics covered
Time taken for FDA approvals
Drug repurposing
Improving safety at mass gatherings
Preventative medicine
Additional resources
If you are interested in learning more about this subject, check out the below content from The GOLD Podcast and GOLD magazine:
